| Financial Year |
March 31 2023 |
| Monetary Funds |
5,436,107,109.99 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
36,087,519.00 |
| Accounts Receivable |
1,954,949,322.21 |
| Advances to Suppliers |
571,191,763.02 |
| Other Receivables |
2,774,743,392.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
908,375.83 |
| Dividend Receivable |
-- |
| Inventories |
2,154,536,029.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
452,670,419.61 |
| Other Current Assets |
589,313,359.24 |
| Total Current Assets |
14,959,936,493.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
282,594,695.73 |
| Long-term Equity Investment |
1,664,110,019.94 |
| Investment Properties |
17,192,402,489.48 |
| Fixed Assetes |
1,687,942,003.10 |
| Under-construction Projects |
1,079,290,936.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,028,181,669.51 |
| R&D expenses |
-- |
| Goodwill |
314,388,553.24 |
| Long-Term Deferred and Prepaid Expenses |
149,237,829.77 |
| Deferred Income Tax Assets |
378,070,813.63 |
| Other Non-Current Assets |
966,456,893.84 |
| Sub-Total of Non-Current Assets |
26,317,809,467.36 |
| Total Assets |
41,277,745,961.23 |
| Short-Term Loans |
5,726,713,437.97 |
| Trading Financial liabilities |
-- |
| Notes Payable |
682,768,921.46 |
| Accounts Payable |
1,076,007,118.81 |
| Accounts Received In Advance |
250,420,777.04 |
| Employee Compensation Payable |
173,921,526.75 |
| Taxes Payable |
393,931,844.01 |
| Interest Payable |
-- |
| Dividend Payable |
2,450,000.00 |
| Other payables |
1,084,670,273.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,415,589,676.41 |
| Other Current Liabilities |
74,722,127.89 |
| Sub-Total of Current Liabilities |
12,481,474,666.97 |
| Long-term Loans |
8,140,778,750.72 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
505,888,308.61 |
| Special Payable |
-- |
| Estimatied Liabilities |
303,248.23 |
| Deferred Income Tax Liabilities |
594,744,286.03 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,229,051,524.93 |
| Total Liabilities |
22,710,526,191.90 |
| Paid-In Capital(Or Share Stock) |
2,802,649,508.00 |
| Capital Surplus |
6,840,369,895.26 |
| Surplus Reserve |
330,045,263.61 |
| LESS:Treasury Stock |
230,720,732.28 |
| Undistributed Profits |
7,527,756,231.79 |
| Minority Stockholder's Interest |
1,043,487,221.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
17,523,732,547.96 |
| Owner's Equity（Stockholder's Equity） |
18,567,219,769.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
41,277,745,961.23 |
